Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions

Pain. 2011 Jan;152(1):140-149. doi: 10.1016/j.pain.2010.10.002. Epub 2010 Oct 30.

Abstract

The proinflammatory cytokine TNF-α has been shown to promote activation and sensitization of primary afferent nociceptors. The downstream signaling processes that play a role in promoting this neuronal response remain however controversial. Increased TNF-α plasma levels during migraine attacks suggest that local interaction between this cytokine and intracranial meningeal nociceptors plays a role in promoting the headache. Here, using in vivo single unit recording in the trigeminal ganglia of anesthetized rats, we show that meningeal TNF-α action promotes a delayed mechanical sensitization of meningeal nociceptors. Using immunohistochemistry, we provide evidence for non-neuronal localization of the TNF receptors TNFR1 to dural endothelial vascular cells and TNFR2 to dural resident macrophages as well as to some CGRP-expressing dural nerve fibers. We also demonstrate that meningeal vascular TNFR1 is co-localized with COX-1 while the perivascular TNFR2 is co-expressed with COX-2. We further report here for the first time that TNF-α evoked sensitization of meningeal nociceptors is dependent upon local action of cyclooxygenase (COX). Finally, we show that local application of TNF-α to the meninges evokes activation of the p38 MAP kinase in dural blood vessels that also express TNFR1 and that pharmacological blockade of p38 activation inhibits TNF-α evoked sensitization of meningeal nociceptors. Our study suggests that meningeal action of TNF-α could play an important role in the genesis of intracranial throbbing headaches such as migraine through a mechanism that involves at least part activation of non-neuronal TNFR1 and TNFR2 and downstream activation of meningeal non-neuronal COX and the p38 MAP kinase.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials / drug effects
  • Animals
  • Cyclooxygenase 1 / metabolism*
  • Disease Models, Animal
  • Dura Mater / cytology
  • Dura Mater / metabolism
  • Endothelial Cells / metabolism
  • Enzyme Inhibitors / pharmacology
  • Hyperalgesia / chemically induced*
  • Hyperalgesia / metabolism*
  • Imidazoles / pharmacology
  • Male
  • Membrane Proteins / metabolism*
  • Physical Stimulation / adverse effects
  • Pyrazoles / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Sensory Receptor Cells / drug effects
  • Sensory Receptor Cells / physiology*
  • Time Factors
  • Trigeminal Ganglion / cytology
  • Tumor Necrosis Factor-alpha / pharmacology*
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Enzyme Inhibitors
  • Imidazoles
  • Membrane Proteins
  • Pyrazoles
  • Pyridines
  • Receptors, Tumor Necrosis Factor, Type I
  • SC 560
  • Tumor Necrosis Factor-alpha
  • Cyclooxygenase 1
  • Ptgs1 protein, rat
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580